Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp. price (AGTC)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

Sector
Health Technology
CEO
Susan B. Washer
Industry
Biotechnology
Exchange
NAS

Top Stories

Coming soon.